IPSEN – Buy-back programme – Art 5 of MAR – Week 22 – 2026
Aggregated presentation by day and by market
| Purchases of own shares from May 25th to May 29th 2026 | ||||||
| Name of the Issuer | Identity code of the Issuer | Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 25/05/2026 | FR0010259150 | 3 000 | 161,8079 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 26/05/2026 | FR0010259150 | 3 500 | 160,9287 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 27/05/2026 | FR0010259150 | 4 000 | 159,3918 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 28/05/2026 | FR0010259150 | 4 500 | 156,1991 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/05/2026 | FR0010259150 | 5 411 | 155,8712 | XPAR |
| TOTAL | 20 411 | 158,3732 | ||||
Attachment

IPSEN – Buy-back programme – Art 5 of MAR – Week 22 – 2026
Aggregated presentation by day and by market
| Purchases of own shares from May 25th to May 29th 2026 | ||||||
| Name of the Issuer | Identity code of the Issuer | Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 25/05/2026 | FR0010259150 | 3 000 | 161,8079 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 26/05/2026 | FR0010259150 | 3 500 | 160,9287 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 27/05/2026 | FR0010259150 | 4 000 | 159,3918 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 28/05/2026 | FR0010259150 | 4 500 | 156,1991 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/05/2026 | FR0010259150 | 5 411 | 155,8712 | XPAR |
| TOTAL | 20 411 | 158,3732 | ||||
Attachment

Related stories
Relever les défis les plus exigeants : l’engagement d’Ipsen au service des besoins médicaux non satisfaits
Pourquoi les données obtenues après autorisation de mise sur le marché redéfinissent l’avenir de la prise en charge des patients
« J’en ai vraiment été témoin, de près » : comment Loubna Ouriaghli a fait de son vécu une force dans sa carrière
Related Press Releases
Ipsen announces the launch of an Employee Shareholding Plan
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen – April 2026- Monthly information relative to the total...
Ipsen initiates a new share buy-back program
Ipsen S.A. – Evolution of the composition of the Board...
Annual General Meeting of Ipsen S.A. held on 13 May...
Ojemda® approved in the European Union as the first targeted...
Ipsen announces that Beech Tree has obtained an exemption from...
Ipsen announces the availability of its 2025 Universal Registration Document
Ipsen – February 2026 – Monthly information relative to the...